Search Results - "Siqueira, Lenicio"

Outcomes of Single Versus Tandem Hematopoietic Stem Cell Autologous Transplant in High-Risk Myeloma Patients: A Single-Center Experience by Philip, Shona, Dehghani, Mina, Siqueira, Lenicio, Quint, Anthony, Lam, Selay, Phua, Chai Wye, Xenocostas, Anargyros, Deotare, Uday, Louzada, Martha L

“…Introduction: Over the past decade, significant advances in the treatment strategy of newly diagnosed multiple myeloma patients (NDMM) have challenged the…”
Get full text

Outcomes of Maintenance Treatment Post Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma Patients: A Canadian Single Center Experience by Dehghani, Mina, Philip, Shona, Quint, Anthony, Siqueira, Lenicio, Lam, Selay, Phua, Chai Wye, Xenocostas, Anargyros, Deotare, Uday, Louzada, Martha L

“…Introduction: Despite the significant advances in treatment of patients with multiple myeloma, therapy of patients with high risk disease remains challenging…”
Get full text

Identifying venous thromboembolism and major bleeding in emergency room discharges using administrative data by Al-Ani, Fatimah, Shariff, Salimah, Siqueira, Lenicio, Seyam, Ayman, Lazo-Langner, Alejandro

“…Abstract Background Administrative data can be used to identify venous thromboembolism (VTE) and major bleeding (MB) events. However, the validity of this data…”
Get full text

Safety of Weight-Adjusted Dosing of LMWH in Clinically Obese Cancer Patients with Venous Thromboembolism by Mount, Gillian, Kovacs, Michael J., Lazo-Langner, Alejandro, Siqueira, Lenicio, Louzada, Martha L

“…Background: Obesity, defined as a body mass index (BMI) greater than 30 kg/m2, is a well-known risk factor for venous thromboembolism (VTE). Despite this…”
Get full text

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism (VTE): A Retrospect of Real Life (EXTEND study - updated results) by Louzada, Martha L, Al-Ani, Fatimah, Kovacs, Michael J., Siqueira, Lenicio, Lazo-Langner, Alejandro

“…Background Last year, we presented at the 56th ASH meeting (abstract 4245) preliminary results of the EXTEND study. We would like to present the complete…”
Get full text

Updates on the Risk of Dalteparin Thromboprophylaxis Failure in Hospitalized Acutely Ill Medical Patients with Cancer (ARTIC STUDY) by Louzada, Martha L, Al-Ani, Fatimah, Kovacs, Michael J., Siqueira, Lenicio, Lazo-Langner, Alejandro

“…Background Hospitalization is a significant risk factor for venous thromboembolism (VTE) with 25% of all VTE occurring in this setting. In patients with cancer…”
Get full text

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism: A Retrospect of Real Life (EXTEND Study) by Louzada, Martha L, Kovacs, Michael J., Al-ani, Fatimah, Siqueira, Lenicio, Lazo-Langner, Alejandro

“…Background: The association between cancer and venous thromboembolism (VTE) has been well documented. In patients with cancer, the risk for a first cancer-…”
Get full text

Assessment of Risk of Thromboprophylaxis Failure in Hospitalized Patients with Cancer (Artic Study) by Louzada, Martha L, Kovacs, Michael J., Al-Ani, FAtimah, Lazo-Langner, Alejandro, Siqueira, Lenicio

“…▪ Background: Venous thromboembolism (VTE) remains the major cause of morbidity and mortality in hospitalized patients. Three randomized placebo controlled…”
Get full text

Comparing the Efficacy of Aspirin or Low Molecular Weight Heparin or Vitamin K Antagonists in the Risk of Thromboembolic Events in Patients with Multiple Myeloma Treated with Lenalidomide-Based Therapy by Louzada, Martha L, Mateos, Maria-Victoria, Siqueira, Lenicio, Bermejo, Jose-Maria B, Ocio, Enrique M, Porras, Jose-Ramon

“…Background Malignancy is a well-recognized risk factor for venous thromboembolism (VTE). In multiple myeloma the incidence of VTE varies between 3% and 10%…”
Get full text